Physician profile
Derek E Kues
NPI 1548718695
$13,536.47
in general payments reported to CMS, 2019-2025
31 companies · $1,774 in 2025
The $1,774 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,760 · 2022: $2,718 · 2023: $1,113 · 2024: $5,172 · 2025: $1,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,743 · Consulting Fee: $1,063 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Education: $423 · Travel and Lodging: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,742.89 |
| Consulting Fee | $1,062.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Education | $423.13 |
| Travel and Lodging | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,708.34 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $1,843.11 | 2021-2025 | |
| Incyte Corporation | $1,320.76 | 2021-2024 | Opzelura |
| Dermavant Sciences, INC. | $754.40 | 2023-2024 | Vtama |
| Pfizer INC. | $728.38 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $693.80 | 2021-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $688.42 | 2021-2025 | Aklief, Twyneo, Epsolay |
| Genzyme Corporation | $628.98 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $526.20 | 2021-2023 | Absorica Ld, Winlevi |
| Lilly USA, LLC | $469.67 | 2021-2025 | Taltz, Ebglyss |
| Amgen INC. | $419.00 | 2021-2024 | Otezla |
| Ucb, INC. | $397.13 | 2021-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $349.19 | 2021-2024 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $303.89 | 2021-2025 | |
| Vyne Pharmaceuticals INC. | $267.60 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prugen, INC. Pharmaceuticals | $245.00 | 2021 | |
| Journey Medical Corporation | $238.72 | 2022 | |
| Organon LLC | $169.58 | 2024-2025 | Vtama |
| Leo Pharma INC. | $145.22 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $135.50 | 2022-2024 | Tremfya |
| Arcutis Biotherapeutics, INC. | $128.49 | 2023-2025 | Zoryve |
| Almirall LLC | $112.22 | 2021-2023 | Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $97.06 | 2021-2024 | Cabtreo |
| Mayne Pharma Commercial LLC | $39.93 | 2023-2025 | |
| Medimetriks Pharmaceuticals, INC. | $29.41 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.29 | 2025 | Spevigo |
| Organogenesis INC. | $16.29 | 2022 | |
| Epi Health, LLC | $15.96 | 2021 | |
| Biofrontera INC. | $15.88 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
| Dermira, INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Kues listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.